As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Subscribe To Our Newsletter & Stay Updated
